Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 9/2014

01.09.2014 | Original Contribution

Striatal volume deficits in children with ADHD who present a poor response to methylphenidate

verfasst von: A. Moreno, L. Duñó, E. Hoekzema, M. Picado, L. M. Martín, J. Fauquet, Y. Vives-Gilabert, A. Bulbena, O. Vilarroya

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Methylphenidate (MPH) is the first choice of medical treatment for attention-deficit/hyperactivity disorder (ADHD). Its mechanism of action is to inhibit the reuptake of dopamine and noradrenaline mainly in the region of the striatum. It has been estimated that 10–30 % of patients with ADHD do not respond adequately to MPH. The aim of this study was to evaluate whether striatal differences exist between good and poor responders to MPH. The sample included 27 treatment-naïve children with ADHD between the ages of 6 and 14. MPH administration started 1 day after the MRI acquisition. After a month, psychiatrists established the good or poor response to treatment according to clinical criteria. MRI images were analyzed using a technique based on regions of interest applied specifically to the caudate and accumbens nuclei. Sixteen patients showed good response to MPH and 11 a poor one. Regions of interest analysis showed that good responders had a higher concentration of gray matter in the head of both caudate nuclei and the right nucleus accumbens. Furthermore, a significant correlation was found between caudate and accumbens nuclei volume and the Conners’ Parent Rating Scale and Continuous Performance Test improvement. These results support the hypothesis of the involvement of the caudate and accumbens nuclei in MPH response and in ADHD pathophysiology.
Literatur
1.
Zurück zum Zitat Achenbach TM, Ruffle TM (2000) The child behavior checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr Rev 21(8):265–271PubMedCrossRef Achenbach TM, Ruffle TM (2000) The child behavior checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr Rev 21(8):265–271PubMedCrossRef
2.
Zurück zum Zitat Almeida Montes LG, Ricardo-Garcell J, De La Torre Barajas LB, Prado Alcántara H, Martínez García RB, Fernández-Bouzas A, Avila Acosta D (2010) Clinical correlations of grey matter reductions in the caudate nucleus of adults with attention deficit hyperactivity disorder. J Psychiatry Neurosci 35(4):238–246PubMedCrossRef Almeida Montes LG, Ricardo-Garcell J, De La Torre Barajas LB, Prado Alcántara H, Martínez García RB, Fernández-Bouzas A, Avila Acosta D (2010) Clinical correlations of grey matter reductions in the caudate nucleus of adults with attention deficit hyperactivity disorder. J Psychiatry Neurosci 35(4):238–246PubMedCrossRef
3.
Zurück zum Zitat Amador-Campos JA, Idiázabal-Alecha MA, Sangorrín-García J, Espadaler-Gamissans JM, Forns-Santacana M (2002) Utilidad de las escalas de Conners para discriminar entre sujetos con y sin trastorno por déficit de atención con hiperactividad. Psicothema 14(2):350–356 Amador-Campos JA, Idiázabal-Alecha MA, Sangorrín-García J, Espadaler-Gamissans JM, Forns-Santacana M (2002) Utilidad de las escalas de Conners para discriminar entre sujetos con y sin trastorno por déficit de atención con hiperactividad. Psicothema 14(2):350–356
4.
Zurück zum Zitat American Psychiatric Association (2004) Diagnostic and statistical manual of mental disorders, 4ª edn. American Psychiatric Association, Washington DC American Psychiatric Association (2004) Diagnostic and statistical manual of mental disorders, 4ª edn. American Psychiatric Association, Washington DC
5.
Zurück zum Zitat Barkley RA (1976) Predicting the response of hyperkinetic children to stimulant drugs: a review. J Abnorm Child Psychol 4(4):327–348PubMedCrossRef Barkley RA (1976) Predicting the response of hyperkinetic children to stimulant drugs: a review. J Abnorm Child Psychol 4(4):327–348PubMedCrossRef
6.
Zurück zum Zitat Blouin B, Maddeaux C, Stanley Firestone J, van Stralen J (2010) Predicting response of ADHD symptoms to methylphenidate treatment based on comorbid anxiety. J Atten Disord 13(4):414–419PubMedCrossRef Blouin B, Maddeaux C, Stanley Firestone J, van Stralen J (2010) Predicting response of ADHD symptoms to methylphenidate treatment based on comorbid anxiety. J Atten Disord 13(4):414–419PubMedCrossRef
7.
Zurück zum Zitat Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M (1995) Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34(8):1025–1032PubMedCrossRef Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M (1995) Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34(8):1025–1032PubMedCrossRef
8.
Zurück zum Zitat Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J (2008) Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry 65(1):102–114PubMedCrossRef Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J (2008) Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry 65(1):102–114PubMedCrossRef
9.
Zurück zum Zitat Carmona S, Proal E, Hoekzema EA, Gispert JD, Picado M, Moreno I, Soliva JC, Bielsa A, Rovira M, Hilferty J, Bulbena A, Casas M, Tobeña A, Vilarroya O (2009) Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/hyperactivity disorder. Biol Psychiatry 66(10):972–977PubMedCrossRef Carmona S, Proal E, Hoekzema EA, Gispert JD, Picado M, Moreno I, Soliva JC, Bielsa A, Rovira M, Hilferty J, Bulbena A, Casas M, Tobeña A, Vilarroya O (2009) Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/hyperactivity disorder. Biol Psychiatry 66(10):972–977PubMedCrossRef
10.
Zurück zum Zitat Castellanos FX, Elia J, Kruesi MJ, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, Hamburger SD, Rapoport JL (1996) Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology 14(2):125–137PubMedCrossRef Castellanos FX, Elia J, Kruesi MJ, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, Hamburger SD, Rapoport JL (1996) Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology 14(2):125–137PubMedCrossRef
11.
Zurück zum Zitat Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, Vaituzis AC, Blumenthal JD, Nelson J, Bastain TM, Zijdenbos A, Evans AC, Rapoport JL (2001) Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58(3):289–295PubMedCrossRef Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, Vaituzis AC, Blumenthal JD, Nelson J, Bastain TM, Zijdenbos A, Evans AC, Rapoport JL (2001) Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58(3):289–295PubMedCrossRef
12.
Zurück zum Zitat Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN, Rapoport JL (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288(14):1740–1748PubMedCrossRef Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN, Rapoport JL (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288(14):1740–1748PubMedCrossRef
13.
Zurück zum Zitat Conners C (2004) Conners’ continuous performance test II version 5 (CPT II V.5). TEA Ediciones, Madrid Conners C (2004) Conners’ continuous performance test II version 5 (CPT II V.5). TEA Ediciones, Madrid
14.
Zurück zum Zitat Conners C, Sitarenios G, Parker J, Epstein J (1998) The revised Conners parent rating scale (CPRS-S): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26(4):257–268PubMedCrossRef Conners C, Sitarenios G, Parker J, Epstein J (1998) The revised Conners parent rating scale (CPRS-S): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26(4):257–268PubMedCrossRef
15.
Zurück zum Zitat Conners C, Sitarenios G, Parker J, Epstein J (1998) Revision and restandardization of the Conners teacher rating scale (StRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26(4):279–291PubMedCrossRef Conners C, Sitarenios G, Parker J, Epstein J (1998) Revision and restandardization of the Conners teacher rating scale (StRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26(4):279–291PubMedCrossRef
16.
Zurück zum Zitat Duong S, Chung K, Wigal SB (2012) Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Expert Opin Drug Metab Toxicol 8(5):543–552PubMedCrossRef Duong S, Chung K, Wigal SB (2012) Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Expert Opin Drug Metab Toxicol 8(5):543–552PubMedCrossRef
17.
Zurück zum Zitat Efron D, Jarman F, Barker M (1997) Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 100(6):E6PubMedCrossRef Efron D, Jarman F, Barker M (1997) Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 100(6):E6PubMedCrossRef
18.
Zurück zum Zitat Epstein JN, Casey BJ, Tonev ST, Davidson MC, Reiss AL, Garrett A, Hinshaw SP, Greenhill LL, Glover G, Shafritz KM, Vitolo A, Kotler LA, Jarrett MA, Spicer J (2007) ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD. J Child Psychol Psychiatry 48(9):899–913PubMedCrossRef Epstein JN, Casey BJ, Tonev ST, Davidson MC, Reiss AL, Garrett A, Hinshaw SP, Greenhill LL, Glover G, Shafritz KM, Vitolo A, Kotler LA, Jarrett MA, Spicer J (2007) ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD. J Child Psychol Psychiatry 48(9):899–913PubMedCrossRef
19.
Zurück zum Zitat Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J (1997) Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48(3):589–601PubMedCrossRef Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J (1997) Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48(3):589–601PubMedCrossRef
20.
Zurück zum Zitat Grizenko N, Kovacina B, Amor LB, Schwartz G, Ter-Stepanian M, Joober R (2006) Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families. J Am Acad Child Adolesc Psychiatry 45(1):47–53PubMedCrossRef Grizenko N, Kovacina B, Amor LB, Schwartz G, Ter-Stepanian M, Joober R (2006) Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families. J Am Acad Child Adolesc Psychiatry 45(1):47–53PubMedCrossRef
21.
Zurück zum Zitat Grupo de trabajo de la Guía de Práctica Clínica sobre el Trastorno por Défi cit de Atención con Hiperactividad (TDAH) en Niños y Adolescentes. Fundació Sant Joan de Déu, coordinador. Guía de Práctica Clínica sobre el Trastorno por Défi cit de Atención con Hiperactividad (TDAH) en Niños y Adolescentes. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad, Política Social e Igualdad. Agència d′Informació, Avaluació i Qualitat (AIAQS) de Cataluña; 2010. Guías de Práctica Clínica en el SNS: AATRM Nº 2007/18 Grupo de trabajo de la Guía de Práctica Clínica sobre el Trastorno por Défi cit de Atención con Hiperactividad (TDAH) en Niños y Adolescentes. Fundació Sant Joan de Déu, coordinador. Guía de Práctica Clínica sobre el Trastorno por Défi cit de Atención con Hiperactividad (TDAH) en Niños y Adolescentes. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad, Política Social e Igualdad. Agència d′Informació, Avaluació i Qualitat (AIAQS) de Cataluña; 2010. Guías de Práctica Clínica en el SNS: AATRM Nº 2007/18
22.
Zurück zum Zitat Gunduz H, Wu H, Ashtari M, Bogerts B, Crandall D, Robinson DG, Alvir J, Lieberman J, Kane J, Bilder R (2002) Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol Psychiatry 51(10):801–808PubMedCrossRef Gunduz H, Wu H, Ashtari M, Bogerts B, Crandall D, Robinson DG, Alvir J, Lieberman J, Kane J, Bilder R (2002) Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol Psychiatry 51(10):801–808PubMedCrossRef
23.
Zurück zum Zitat Guy W (1976) Early Clinical Drug Evaluation (ECDEU) assessment manual for psychopharmacology. National Institute of Mental Health, Washington DC Guy W (1976) Early Clinical Drug Evaluation (ECDEU) assessment manual for psychopharmacology. National Institute of Mental Health, Washington DC
24.
Zurück zum Zitat Hale JB, Reddy LA, Semrud-Clikeman M, Hain LA, Whitaker J, Morley J, Lawrence K, Smith A, Jones N (2011) Executive impairment determines ADHD medication response: implications for academic achievement. J Learn Disabil 44(2):196–212PubMedCrossRef Hale JB, Reddy LA, Semrud-Clikeman M, Hain LA, Whitaker J, Morley J, Lawrence K, Smith A, Jones N (2011) Executive impairment determines ADHD medication response: implications for academic achievement. J Learn Disabil 44(2):196–212PubMedCrossRef
25.
Zurück zum Zitat Hoekzema E, Carmona S, Ramos-Quiroga JA, Canals C, Moreno A, Fernández VR, Picado M, Bosch R, Duñó L, Soliva JC, Rovira M, Bulbena A, Tobeña A, Casas M, Vilarroya O (2012) Stimulant drugs trigger transient volumetric changes in the human ventral striatum. Brain Struct Funct. doi:10.1007/s00429-012-0481-7 PubMed Hoekzema E, Carmona S, Ramos-Quiroga JA, Canals C, Moreno A, Fernández VR, Picado M, Bosch R, Duñó L, Soliva JC, Rovira M, Bulbena A, Tobeña A, Casas M, Vilarroya O (2012) Stimulant drugs trigger transient volumetric changes in the human ventral striatum. Brain Struct Funct. doi:10.​1007/​s00429-012-0481-7 PubMed
26.
Zurück zum Zitat Ilgin N, Senol S, Gucuyener K, Gokcora N, Sener S (2001) Is increased D2 receptor availability associated with response to stimulant medication in ADHD. Dev Med Child Neurol 43(11):755–760PubMedCrossRef Ilgin N, Senol S, Gucuyener K, Gokcora N, Sener S (2001) Is increased D2 receptor availability associated with response to stimulant medication in ADHD. Dev Med Child Neurol 43(11):755–760PubMedCrossRef
27.
Zurück zum Zitat Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980–988PubMedCrossRef Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980–988PubMedCrossRef
28.
Zurück zum Zitat Mahone EM, Crocetti D, Ranta ME, Gaddis A, Cataldo M, Slifer KJ, Denckla MB, Mostofsky SH (2011) A preliminary neuroimaging study of preschool children with ADHD. Clin Neuropsychol 25(6):1009–1028PubMedCrossRef Mahone EM, Crocetti D, Ranta ME, Gaddis A, Cataldo M, Slifer KJ, Denckla MB, Mostofsky SH (2011) A preliminary neuroimaging study of preschool children with ADHD. Clin Neuropsychol 25(6):1009–1028PubMedCrossRef
29.
Zurück zum Zitat MTA cooperative group (2004) National Institute of Mental Health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113(4):762–769CrossRef MTA cooperative group (2004) National Institute of Mental Health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113(4):762–769CrossRef
30.
Zurück zum Zitat Mulas F, Roselló B, Morant A, Hernández S, Pitarch I (2002) Efectos de los psicoestimulantes en el desempeño cognitivo y conductual de los niños con un déficit de atención con hiperactividad subtipo combinado. Rev Neurol 35(1):17–24PubMed Mulas F, Roselló B, Morant A, Hernández S, Pitarch I (2002) Efectos de los psicoestimulantes en el desempeño cognitivo y conductual de los niños con un déficit de atención con hiperactividad subtipo combinado. Rev Neurol 35(1):17–24PubMed
31.
Zurück zum Zitat Nakao T, Radua J, Rubia K, Mataix-Cols D (2011) Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry 168(11):1154–1163PubMedCrossRef Nakao T, Radua J, Rubia K, Mataix-Cols D (2011) Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry 168(11):1154–1163PubMedCrossRef
32.
Zurück zum Zitat Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T (2003) Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol 71(3):540–552PubMedCrossRef Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T (2003) Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol 71(3):540–552PubMedCrossRef
33.
Zurück zum Zitat Pelham WE Jr, Walker JL, Sturges J, Hoza J (1989) Comparative effects of methylphenidate on ADD girls and ADD boys. J Am Acad Child Adolesc Psychiatry 28(5):773–776PubMedCrossRef Pelham WE Jr, Walker JL, Sturges J, Hoza J (1989) Comparative effects of methylphenidate on ADD girls and ADD boys. J Am Acad Child Adolesc Psychiatry 28(5):773–776PubMedCrossRef
34.
Zurück zum Zitat Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6):942–948PubMedCrossRef Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6):942–948PubMedCrossRef
35.
Zurück zum Zitat Rapport MD, Denney C (1997) Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: is body mass predictive of clinical response? J Am Acad Child Adolesc Psychiatry 36(4):523–530PubMedCrossRef Rapport MD, Denney C (1997) Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: is body mass predictive of clinical response? J Am Acad Child Adolesc Psychiatry 36(4):523–530PubMedCrossRef
36.
Zurück zum Zitat Riccio CA, Waldrop JJ, Reynolds CR, Lowe P (2001) Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13(3):326–335PubMedCrossRef Riccio CA, Waldrop JJ, Reynolds CR, Lowe P (2001) Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13(3):326–335PubMedCrossRef
37.
Zurück zum Zitat Rubia K, Halari R, Cubillo A, Smith AB, Mohammad AM, Brammer M, Taylor E (2011) Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology 36(8):1575–1586PubMedCentralPubMedCrossRef Rubia K, Halari R, Cubillo A, Smith AB, Mohammad AM, Brammer M, Taylor E (2011) Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology 36(8):1575–1586PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Rubio B, Hernández S, Verche E, Martín R, González-Pérez P (2011) A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities. Atten Defic Hyperact Disord 3(1):13–20PubMedCrossRef Rubio B, Hernández S, Verche E, Martín R, González-Pérez P (2011) A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities. Atten Defic Hyperact Disord 3(1):13–20PubMedCrossRef
39.
Zurück zum Zitat Scheres A, Oosterlaan J, Sergeant JA (2006) Speed of inhibition predicts teacher-rated medication response in boys with attention deficit hyperactivity disorder. IJDDE 53:93–109 Scheres A, Oosterlaan J, Sergeant JA (2006) Speed of inhibition predicts teacher-rated medication response in boys with attention deficit hyperactivity disorder. IJDDE 53:93–109
40.
Zurück zum Zitat Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S (1983) A children’s global assessment scale (CGAS). Arch Gen Psychiatry 40(11):1228–1231PubMedCrossRef Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S (1983) A children’s global assessment scale (CGAS). Arch Gen Psychiatry 40(11):1228–1231PubMedCrossRef
41.
Zurück zum Zitat Shekim WO, Javaid J, Davis JM, Bylund DB (1983) Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Biol Psychiatry 18(6):707–714PubMed Shekim WO, Javaid J, Davis JM, Bylund DB (1983) Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Biol Psychiatry 18(6):707–714PubMed
42.
Zurück zum Zitat Solanto M, Newcorn J, Vail L, Gilbert S, Ivanov I, Lara R (2009) Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19(6):663–671PubMedCentralPubMedCrossRef Solanto M, Newcorn J, Vail L, Gilbert S, Ivanov I, Lara R (2009) Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19(6):663–671PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the state/trait anxiety inventory in children (version española TEA 1988). Consulting Psychologists Press, Palo Alto Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the state/trait anxiety inventory in children (version española TEA 1988). Consulting Psychologists Press, Palo Alto
44.
Zurück zum Zitat Ter-Stepanian M, Grizenko N, Zappitelli M, Joober R (2010) Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. Can J Psychiatry 55(5):305–312PubMed Ter-Stepanian M, Grizenko N, Zappitelli M, Joober R (2010) Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. Can J Psychiatry 55(5):305–312PubMed
45.
Zurück zum Zitat The MTA cooperative group (1999) Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multimodal treatment study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56(12):1088–1096CrossRef The MTA cooperative group (1999) Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multimodal treatment study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56(12):1088–1096CrossRef
46.
Zurück zum Zitat Tremols V, Bielsa A, Soliva JC, Raheb C, Carmona S, Tomas J, Gispert JD, Rovira M, Fauquet J, Tobeña A, Bulbena A, Vilarroya O (2008) Differential abnormalities of the head and body of the caudate nucleus in attention deficit-hyperactivity disorder. Psychiatry Res 163(3):270–278PubMedCrossRef Tremols V, Bielsa A, Soliva JC, Raheb C, Carmona S, Tomas J, Gispert JD, Rovira M, Fauquet J, Tobeña A, Bulbena A, Vilarroya O (2008) Differential abnormalities of the head and body of the caudate nucleus in attention deficit-hyperactivity disorder. Psychiatry Res 163(3):270–278PubMedCrossRef
47.
Zurück zum Zitat van der Oord S, Geurts HM, Prins PJ, Emmelkamp PM, Oosterlaan J (2012) Prepotent response inhibition predicts treatment outcome in attention deficit/hiperactivity disorder. Child Neuropsychol 18(1):50–61PubMedCrossRef van der Oord S, Geurts HM, Prins PJ, Emmelkamp PM, Oosterlaan J (2012) Prepotent response inhibition predicts treatment outcome in attention deficit/hiperactivity disorder. Child Neuropsychol 18(1):50–61PubMedCrossRef
48.
Zurück zum Zitat van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM (2008) Treatment of attention deficit hyperactivity disorder in children. Eur Child Adolesc Psychiatry 17(2):73–81PubMedCrossRef van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM (2008) Treatment of attention deficit hyperactivity disorder in children. Eur Child Adolesc Psychiatry 17(2):73–81PubMedCrossRef
49.
Zurück zum Zitat Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM (2004) Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 161(7):1173–1180PubMedCrossRef Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM (2004) Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 161(7):1173–1180PubMedCrossRef
50.
Zurück zum Zitat Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM (2012) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci 32(3):841–849PubMedCentralPubMedCrossRef Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM (2012) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci 32(3):841–849PubMedCentralPubMedCrossRef
51.
Zurück zum Zitat Wechsler D (2005) Escala de Inteligencia de Wechsler para niños (WISC-IV). TEA Ediciones, Madrid Wechsler D (2005) Escala de Inteligencia de Wechsler para niños (WISC-IV). TEA Ediciones, Madrid
52.
Zurück zum Zitat Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM (2009) Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study. Neuroimage 46(1):31–38PubMedCentralPubMedCrossRef Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM (2009) Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study. Neuroimage 46(1):31–38PubMedCentralPubMedCrossRef
53.
Zurück zum Zitat Yildiz O, Sismanlar SG, Memik NC, Karakaya I, Agaoglu B (2011) Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Child Psychiatry Hum Dev 42(3):257–269PubMedCrossRef Yildiz O, Sismanlar SG, Memik NC, Karakaya I, Agaoglu B (2011) Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Child Psychiatry Hum Dev 42(3):257–269PubMedCrossRef
54.
Zurück zum Zitat Zalsman G, Pumeranz O, Peretz G, Ben-Dor DH, Dekel S, Horesh N, Fischel T, Nahshoni E, Goldberg PH, Sever J, Apter A (2003) Attention patterns in children with attention deficit disorder with or without hyperactivity. Sci World J 3:1093–1107CrossRef Zalsman G, Pumeranz O, Peretz G, Ben-Dor DH, Dekel S, Horesh N, Fischel T, Nahshoni E, Goldberg PH, Sever J, Apter A (2003) Attention patterns in children with attention deficit disorder with or without hyperactivity. Sci World J 3:1093–1107CrossRef
Metadaten
Titel
Striatal volume deficits in children with ADHD who present a poor response to methylphenidate
verfasst von
A. Moreno
L. Duñó
E. Hoekzema
M. Picado
L. M. Martín
J. Fauquet
Y. Vives-Gilabert
A. Bulbena
O. Vilarroya
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 9/2014
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-013-0510-y

Weitere Artikel der Ausgabe 9/2014

European Child & Adolescent Psychiatry 9/2014 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.